Apple is reportedly developing its smartwatch technologies through new partnerships

By Catherine Sturman
Apple is continually developing its smartwatch capabilities, understanding that its innovations within healthcare will open the door to further market o...

Apple is continually developing its smartwatch capabilities, understanding that its innovations within healthcare will open the door to further market opportunities.

It has been reported that Apple is working with Stanford clinicians and American Well to further its smartwatch technologies and enable it to detect common heart conditions and abnormalities through the use of sensors.

If successful, the company will see a steady rise in revenue by catering towards high-risk patients, with information that is over 90% accurate. Both Stanford and American Well have declined to comment.

Related stories

At present, Apple’s Series 3 provides useful information surrounding a user’s health as a result of its interest in fitness applications. The Apple Watch app can also detect any irregularities with over 95% accuracy.

Apple’s previous partnership with health app Cardiogram has also highlighted the company’s focus in cardiology and health screening. In 2016,

However, through this new partnership, Apple will develop its technology further, especially with regards to health recovery times, and whether there is the potential for undiagnosed health conditions, such as atrial fibrillation, to be bought to light.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare